APR 06, 2016 10:30 AM PDT

Microbiome Biomarker Discovery for Diagnostic and Therapeutic Applications

Speaker

Abstract

Microbiome discovery efforts are underway in multiple disease areas.  Challenges exist in sample collection, processing, assay selection and bioinformatics.  Therefore heterogeneity exists in published findings for biomarkers.  Using the Amazon cloud and machine learning, sets of consistent biomarkers can be observed in biospecimens from diseased subjects that differentiate them from healthy controls.  The benefits of applying consistent assays with internal controls within each test will be discussed.  Since the same data collected for diagnostic discovery, also aids in therapeutic hypotheses generation, a platform that outputs both will be outlined.
 
Learning Objectives:
- Be able to list at least 2 disease areas where microbiome analyses are applied.
- Be able to list at least 2 sources of variation in biomarker discovery in microbiome analyses.
- Be able to identify the benefits of internal controls in evaluating assay value.
 


Show Resources
You May Also Like
JUN 21, 2022 6:00 AM PDT
JUN 21, 2022 6:00 AM PDT
Date: June 21, 2022 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST) The global understanding and practice of medicine is currently undergoing a revolutionary change. This shift to precision...
JUN 28, 2022 7:00 AM PDT
JUN 28, 2022 7:00 AM PDT
Date: June 28, 2022 Time: 3:00pm (BST), 4:00pm (CET), 9:00am (CST), 7am (PST) Light-sheet microscopy is an extremely versatile imaging technique with a vast range of implementations that are...
MAR 23, 2022 11:00 AM PDT
MAR 23, 2022 11:00 AM PDT
Date: March 23, 2021 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEDT) In this presentation, Dr. Middleton will review the development and deployment of large-scale saliva-based COVID-19 test...
AUG 10, 2022 10:00 AM PDT
AUG 10, 2022 10:00 AM PDT
Date: August 10, 2022 Time: 10:00am PDT, 1:00pm EDT The global pandemic has increased focus and scrutiny on molecular diagnostic assay development, resulting in a need for assays that provid...
MAY 19, 2022 8:00 AM PDT
MAY 19, 2022 8:00 AM PDT
Date: May 19, 2022 Time: 8:00am (PDT), 11:00pm (EDT), 5:00pm (CEST) Mass spectrometry (MS)-based proteomic technologies are increasingly applied in a clinical context for disease classific...
AUG 09, 2022 11:00 AM PDT
AUG 09, 2022 11:00 AM PDT
Date: August 9, 2022 Time: 11:00am (PST), 2:00pm (EST), 8:00pm (CEST) Antimicrobial resistance (AMR) has emerged as a major health threat. The FED-AMR project part of the One Health European...
APR 06, 2016 10:30 AM PDT

Microbiome Biomarker Discovery for Diagnostic and Therapeutic Applications



Show Resources
Loading Comments...
Show Resources
Attendees